950130.KQ
Access Bio, Inc.
KOE · Healthcare · Medical - Diagnostics & Research · US
KRW 2,525.00
+0.60%Margins
Gross margin
-138.2%
EBITDA margin
-432.0%
EBIT margin
-295.2%
Net margin
-466.9%
FCF margin
-109.2%
-20.8%
Return on equity
-17.5%
Return on assets
-11.5%
Return on invested capital
0.04x
Asset turnover
-KRW 24.7B
Cash from operations
KRW 9.2K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026